YESINTEK
NDC 83257-026, ustekinumab, solution, from Biocon Biologics Inc..
- Product NDC
- 83257-026
- Status
- Listed
- Labeler
- Biocon Biologics Inc.
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761406
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/83257-026 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- USTEKINUMAB130 mg/26mL
Pharmacologic classes
Interleukin-12 Antagonist [EPC]; Interleukin-12 Antagonists [MoA]; Interleukin-23 Antagonist [EPC]; Interleukin-23 Antagonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 83257-026-11 | 83257002611 | 1 VIAL, SINGLE-USE in 1 BOX (83257-026-11) / 26 mL in 1 VIAL, SINGLE-USE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/12a75613-ee33-d30a-215b-2a51cfa19b00Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=83257-026
Use it
Look up 83257-026 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/83257-026 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 83257-026. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.